HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1901	2181 KISILEVSKY R, LYON AW, YOUNG ID A CRITICAL ANALYSIS OF POSTULATED PATHOGENETIC MECHANISMS IN AMYLOIDOGENESIS CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. 1992; 29 (1): 59-82	3	31	6	146
1902	4768 delaTorre JC Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE. 1997; 826: 75-91	7	54	4	146
1903	5799 Rowland LP Molecular basis of genetic heterogeneity: Role of the clinical neurologist JOURNAL OF CHILD NEUROLOGY. 1998 MAR; 13 (3): 122-132	1	7	3	146
1904	5890 Rao BR Isolation and characterization of an estrogen binding protein which may integrate the plethora of estrogenic actions in nonreproductive organs JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 1998 APR; 65 (1-6): 3-41	0	28	5	146
1905	6529 Litvan I Progressive supranuclear palsy revisited (vol 98, pg 73, 1998) ACTA NEUROLOGICA SCANDINAVICA. 1998 DEC; 98 (6): 468-A84	1	1	12	146
1906	7866 Kvetnoy IM, Hernandez-Yago J, Hernandez JM, Kvetnaia TV, Reiter RJ, et al. Diffuse neuroendocrine system and mitochondrial diseases: molecular and cellular bases of pathogenesis, new approaches to diagnosis and therapy. NEUROENDOCRINOLOGY LETTERS. 2000; 21 (2): 83-99	0	3	14	146
1907	8022 Philips AV, Cooper TA RNA processing and human disease CELLULAR AND MOLECULAR LIFE SCIENCES. 2000 FEB; 57 (2): 235-249	5	80	3	146
1908	8597 Shoichet MS, Winn SR Cell delivery to the central nervous system ADVANCED DRUG DELIVERY REVIEWS. 2000 AUG 20; 42 (1-2): 81-102	5	30	11	146
1909	8645 Alvarado MC, Bachevalier J Revisiting the maturation of medial temporal lobe memory functions in primates LEARNING & MEMORY. 2000 SEP-OCT; 7 (5): 244-256	1	30	2	146
1910	9528 Fuster JM The prefrontal cortex - An update: time is of the essence NEURON. 2001 MAY; 30 (2): 319-333	3	418	15	146
#	Date / Author / Journal	LCS	GCS	LCR	CR
1911	9697 Chambers RA, Krystal JH, Self DW A neurobiological basis for substance abuse comorbidity in schizophrenia BIOLOGICAL PSYCHIATRY. 2001 JUL 15; 50 (2): 71-83	3	143	2	146
1912	10452 Springer JE Apoptotic cell death following traumatic injury to the central nervous system JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2002 JAN 31; 35 (1): 94-105	4	19	22	146
1913	10801 Grundman M, Delaney P Antioxidant strategies for Alzheimer's disease PROCEEDINGS OF THE NUTRITION SOCIETY. 2002 MAY; 61 (2): 191-202	8	79	6	146
1914	11059 Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, et al. Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice JOURNAL OF COMPARATIVE NEUROLOGY. 2002 JUL 29; 449 (3): 241-269	3	46	35	146
1915	13028 Shah AC, Benos D, Gillespie GY, Markert JM Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas JOURNAL OF NEURO-ONCOLOGY. 2003 DEC; 65 (3): 203-226	7	61	9	146
1916	13636 Barcia-Gonzalez C, Herrero-Ezquerro MT Inflammation and Parkinson's disease REVISTA DE NEUROLOGIA. 2004 MAR 16; 38 (6): 545-553	0	5	6	146
1917	13791 Kreuter M, Langer C, Kerkhoff C, Reddanna P, Kania AL, et al. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2004 MAY-JUN; 52 (3): 141-155	1	23	20	146
1918	14097 Fujimoto ST, Longhi L, Saatman KE, McIntosh TK Motor and cognitive function evaluation following experimental traumatic brain injury NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2004 JUL; 28 (4): 365-378	26	63	29	146
1919	14611 Rao RV, Bredesen DE Misfolded proteins, endoplasmic reticulum stress and neurodegeneration CURRENT OPINION IN CELL BIOLOGY. 2004 DEC; 16 (6): 653-662	13	89	23	146
1920	15565 Hoerndli F, David DC, Gotz J Functional genomics meets neurodegenerative disorders Part II: Application and data integration PROGRESS IN NEUROBIOLOGY. 2005 JUN; 76 (3): 169-188	13	21	58	146
#	Date / Author / Journal	LCS	GCS	LCR	CR
1921	15846 Gille G, Reichmann H Update on etiopathogenesis of idiopathic Parkinson's syndrome AKTUELLE NEUROLOGIE. 2005 SEP; 32: S75-S87	0	0	42	146
1922	16433 Gilgun-Sherki Y, Melamed E, Offen D Anti-inflammatory drugs in the treatment of neurodegenerative diseases: Current state CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (27): 3509-3519	1	12	4	146
1923	18256 Gnanapavan S, Giovannoni G Incorporation of other biomarkers NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207	0	0	42	146
1924	18294 Biasca N, Maxwell WL Minor traumatic brain injury in sports: a review in order to prevent neurological sequelae NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 263-291	1	7	16	146
1925	19010 Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation PROCEEDINGS OF THE NUTRITION SOCIETY. 2007 MAY; 66 (2): 183-197	0	22	1	146
1926	19109 Walsh DM, Selkoe DJ A beta Oligomers - a decade of discovery JOURNAL OF NEUROCHEMISTRY. 2007 JUN; 101 (5): 1172-1184	82	334	17	146
1927	19288 LaFerla FM, Green KN, Oddo S Intracellular amyloid-beta in Alzheimer's disease NATURE REVIEWS NEUROSCIENCE. 2007 JUL; 8 (7): 499-509	71	231	26	146
1928	20775 Nathalie P, Jean-Noel O Processing of amyloid precursor protein and amyloid peptide neurotoxicity CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 92-99	3	11	32	146
1929	22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406	5	12	47	146
1930	22742 Weiss MJ, dos Santos CO Chaperoning erythropoiesis BLOOD. 2009 MAR 5; 113 (10): 2136-2144	0	6	11	146
#	Date / Author / Journal	LCS	GCS	LCR	CR
1931	24929 Selvaraj S, Sun YY, Singh BB TRPC Channels and their Implications for Neurological Diseases CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 MAR; 9 (1): 94-104	1	3	10	146
1932	25070 Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH Mechanisms Underlying Inflammation in Neurodegeneration CELL. 2010 MAR 19; 140 (6): 918-934	7	40	32	146
1933	25169 Schwartz M, Shechter R Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease MOLECULAR PSYCHIATRY. 2010 APR; 15 (4): 342-354	2	4	3	146
1934	25246 Yeager MP, Coleman RA In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease JOURNAL OF NEUROSCIENCE METHODS. 2010 APR 30; 188 (1): 151-164	0	0	65	146
1935	26777 Tyther R, McDonagh B, Sheehan D PROTEOMICS IN INVESTIGATION OF PROTEIN NITRATION IN KIDNEY DISEASE: TECHNICAL CHALLENGES AND PERSPECTIVES FROM THE SPONTANEOUSLY HYPERTENSIVE RAT MASS SPECTROMETRY REVIEWS. 2011 JAN-FEB; 30 (1): 121-141	0	0	20	146
1936	844 LEICHNETZ GR AFFERENT AND EFFERENT CONNECTIONS OF THE DORSOLATERAL PRECENTRAL GYRUS (AREA-4, HAND ARM REGION) IN THE MACAQUE MONKEY, WITH COMPARISONS TO AREA-8 JOURNAL OF COMPARATIVE NEUROLOGY. 1986 DEC 22; 254 (4): 460-492	11	164	16	145
1937	3726 HOF PR, GIANNAKOPOULOS P, VICKERS JC, BOURAS C, MORRISON JH THE MORPHOLOGIC AND NEUROCHEMICAL BASIS OF DEMENTIA - AGING, HIERARCHICAL PATTERNS OF LESION DISTRIBUTION AND VULNERABLE NEURONAL PHENOTYPE REVIEWS IN THE NEUROSCIENCES. 1995 APR-JUN; 6 (2): 97-124	8	18	22	145
1938	5277 Verbeek MM, Ruiter DJ, deWaal RMW The role of amyloid in the pathogenesis of Alzheimer's disease BIOLOGICAL CHEMISTRY. 1997 SEP; 378 (9): 937-950	2	25	17	145
1939	9322 Grant P, Sharma P, Pant HC Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism EUROPEAN JOURNAL OF BIOCHEMISTRY. 2001 MAR; 268 (6): 1534-1546	12	72	52	145
1940	10009 Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, et al. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2001 NOV; 21 (11): 1241-1258	22	22	41	145
#	Date / Author / Journal	LCS	GCS	LCR	CR
1941	10653 Isacson O Models of repair mechanisms for future treatment modalities of Parkinson's disease BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 839-846	8	17	13	145
1942	11007 Gwinn-Hardy K Genetics of parkinsonism MOVEMENT DISORDERS. 2002 JUL; 17 (4): 645-656	23	72	52	145
1943	12017 Huang ZA, de la Fuente-Fernandez R, Stoessl AJ Etiology of Parkinson's disease CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2003 MAR; 30: S10-S18	0	10	29	145
1944	13124 Willcox JK, Ash SL, Catignani GL Antioxidants and prevention of chronic disease CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION. 2004; 44 (4): 275-295	1	138	5	145
1945	13671 Rao RV, Ellerby HM, Bredesen DE Coupling endoplasmic reticulum stress to the cell death program CELL DEATH AND DIFFERENTIATION. 2004 APR; 11 (4): 372-380	14	296	11	145
1946	13682 Sidhu A, Wersinger C, Vernier P Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB JOURNAL. 2004 APR; 18 (6): 637-647	46	65	97	145
1947	13833 Verdier Y, Zarandi M, Penke B Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer's disease JOURNAL OF PEPTIDE SCIENCE. 2004 MAY; 10 (5): 229-248	12	87	18	145
1948	14106 Nakaya K Basic studies for the development of anticancer, antidementia, and taste modifier drugs YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. 2004 JUL; 124 (7): 371-396	0	0	23	145
1949	15128 Pereira AA, Weiner DE, Scott T, Sarnak MJ Cognitive function in dialysis patients AMERICAN JOURNAL OF KIDNEY DISEASES. 2005 MAR; 45 (3): 448-462	1	40	5	145
1950	15270 Marchetti B, Serra PA, Tirolo C, L'Episcopo F, Caniglia S, et al. Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions BRAIN RESEARCH REVIEWS. 2005 APR; 48 (2): 302-321	2	21	7	145
#	Date / Author / Journal	LCS	GCS	LCR	CR
1951	15272 Schmidt OI, Heyde CE, Ertel W, Stahel PF Closed head injury - an inflammatory disease? BRAIN RESEARCH REVIEWS. 2005 APR; 48 (2): 388-399	14	61	16	145
1952	15521 Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX Metals and amyloid-beta in Alzheimer's disease INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 2005 JUN; 86 (3): 147-159	21	90	19	145
1953	16019 Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2005 OCT; 47 (10): 1059-1087	4	25	23	145
1954	16966 Chaudhuri TK, Paul S Protein-misfolding diseases and chaperone-based therapeutic approaches FEBS JOURNAL. 2006 APR; 273 (7): 1331-1349	14	70	34	145
1955	17995 Rubin CD The primary care of Alzheimer disease AMERICAN JOURNAL OF THE MEDICAL SCIENCES. 2006 DEC; 332 (6): 314-333	1	6	6	145
1956	19095 Quinones-Hinojosa A, Chaichana K The human subventricular zone: A source of new cells and a potential source of brain tumors EXPERIMENTAL NEUROLOGY. 2007 JUN; 205 (2): 313-324	3	24	12	145
1957	20463 Hess DC, Borlongan CV Stem cells and neurological diseases CELL PROLIFERATION. 2008 FEB; 41: 94-114	8	43	24	145
1958	20564 Alavian KN, Scholz C, Simon HH Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death MOVEMENT DISORDERS. 2008 FEB 15; 23 (3): 319-328	7	20	8	145
1959	20609 Otzen D, Nielsen PH We find them here, we find them there: Functional bacterial amyloid CELLULAR AND MOLECULAR LIFE SCIENCES. 2008 MAR; 65 (6): 910-927	0	18	9	145
1960	21575 Martinez A Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs MEDICINAL RESEARCH REVIEWS. 2008 SEP; 28 (5): 773-796	2	18	14	145
#	Date / Author / Journal	LCS	GCS	LCR	CR
1961	22102 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS. 2009; 10 (3): 131-146	12	24	36	145
1962	22676 Beyer K, Domingo-Sabat M, Ariza A Molecular Pathology of Lewy Body Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745	6	7	86	145
1963	22830 Fatemi SH POTENTIAL MICROBIAL ORIGINS OF SCHIZOPHRENIA AND THEIR TREATMENTS DRUGS OF TODAY. 2009 APR; 45 (4): 305-318	0	1	11	145
1964	23361 Friedman GK, Pressey JG, Reddy AT, Markert JM, Gillespie GY Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies MOLECULAR THERAPY. 2009 JUL; 17 (7): 1125-1135	1	3	13	145
1965	23632 Fernandes A, Brites D Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents CURRENT PHARMACEUTICAL DESIGN. 2009 SEP; 15 (25): 2915-2926	0	1	7	145
1966	24464 Fahn S Parkinson's Disease: 10 Years of Progress, 1997-2007 MOVEMENT DISORDERS. 2010; 25 (3): S2-S14	0	0	33	145
1967	3527 Jellinger KA Neurodegenerative disorders with extrapyramidal features - A neuropathological overview JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1995; (46): 33-57	0	0	17	144
1968	4556 Beauregard M, Bachevalier J Neonatal insult to the hippocampal region and schizophrenia: A review and a putative animal model CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 1996 SEP; 41 (7): 446-456	2	26	3	144
1969	4942 PallaresTrujillo J, Agell N, GarciaMartinez C, LopezSoriano FJ, Argiles JM The ubiquitin system: A role in disease? MEDICINAL RESEARCH REVIEWS. 1997 MAR; 17 (2): 139-161	0	6	12	144
1970	5079 daSilva HAR, Patel AJ Presenilins and early-onset familial Alzheimer's disease NEUROREPORT. 1997 MAY 27; 8 (8): R1-R12	0	0	7	144
#	Date / Author / Journal	LCS	GCS	LCR	CR
1971	5318 Price DL, Wong PC, Borchelt DR, Pardo CA, Thinakaran G, et al. Amyotrophic lateral sclerosis and Alzheimer's disease. Lessons from model systems REVUE NEUROLOGIQUE. 1997 SEP; 153 (8-9): 484-495	2	7	13	144
1972	7514 Herschkowitz N, Kagan J, Zilles K Neurobiological bases of behavioral development in the second year NEUROPEDIATRICS. 1999 OCT; 30 (5): 221-230	1	15	3	144
1973	9075 Lowe J, Mayer J, Landon M, Layfield R Ubiquitin and the molecular pathology of neurodegenerative diseases NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 169-186	10	27	48	144
1974	11460 Morelli L, Llovera R, Ibendahl S, Castano EM The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses NEUROCHEMICAL RESEARCH. 2002 NOV; 27 (11): 1387-1399	1	12	8	144
1975	14381 Schulz JB, Falkenburger BH Neuronal pathology in Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 135-147	7	22	34	144
1976	14907 Povlishock JT, Katz DI Update of neuropathology and neurological recovery after traumatic brain injury JOURNAL OF HEAD TRAUMA REHABILITATION. 2005 JAN-FEB; 20 (1): 76-94	22	102	29	144
1977	15407 Spires TL, Hannan AJ Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease - FEBS anniversary prize lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw FEBS JOURNAL. 2005 MAY; 272 (10): 2347-2361	4	42	10	144
1978	19428 Tilleux S, Hermans E Neuroinflammation and regulation of glial glutamate uptake in neurological disorders JOURNAL OF NEUROSCIENCE RESEARCH. 2007 AUG 1; 85 (10): 2059-2070	4	41	10	144
1979	19784 Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA gamma-synuclein and the progression of cancer FASEB JOURNAL. 2007 NOV; 21 (13): 3419-3430	7	11	97	144
1980	19881 Klein C, Schlossmacher MG Parkinson disease, 10 years after its genetic revolution - Multiple clues to a complex disorder NEUROLOGY. 2007 NOV 27; 69 (22): 2093-2104	19	55	46	144
#	Date / Author / Journal	LCS	GCS	LCR	CR
1981	20063 Sano M, Grossman H, Van Dyk K Preventing Alzheimer's Disease Separating Fact From Fiction CNS DRUGS. 2008; 22 (11): 887-902	2	6	6	144
1982	21163 Schiesling C, Kieper N, Seidel K, Kruger R Review: Familial Parkinson's disease - genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 JUN; 34 (3): 255-271	12	24	58	144
1983	22878 Head E Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging NEUROCHEMICAL RESEARCH. 2009 APR; 34 (4): 670-678	2	7	23	144
1984	23653 Green KN Calcium in the initiation, progression and as an effector of Alzheimer's disease pathology JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 SEP; 13 (9A): 2787-2799	2	3	21	144
1985	24032 Mason C, Dunnill P Assessing the value of autologous and allogeneic cells for regenerative medicine REGENERATIVE MEDICINE. 2009 NOV; 4 (6): 835-853	0	2	6	144
1986	24919 Crews L, Rockenstein E, Masliah E APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 111-126	2	4	32	144
1987	25608 Sreedharan J Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics? CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 259-267	0	0	42	144
1988	834 HUERTA MF, KRUBITZER LA, KAAS JH FRONTAL EYE FIELD AS DEFINED BY INTRACORTICAL MICROSTIMULATION IN SQUIRREL-MONKEYS, OWL MONKEYS, AND MACAQUE MONKEYS .1. SUBCORTICAL CONNECTIONS JOURNAL OF COMPARATIVE NEUROLOGY. 1986 NOV 22; 253 (4): 415-439	19	238	23	143
1989	6180 Litvan I Progressive supranuclear palsy revisited ACTA NEUROLOGICA SCANDINAVICA. 1998 AUG; 98 (2): 73-84	8	24	11	143
1990	7239 Arnold SE Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology DEVELOPMENT AND PSYCHOPATHOLOGY. 1999 SUM; 11 (3): 439-456	6	53	22	143
#	Date / Author / Journal	LCS	GCS	LCR	CR
1991	9762 Sathasivam S, Ince PG, Shaw PJ Apoptosis in amyotrophic lateral sclerosis: a review of the evidence NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 AUG; 27 (4): 257-274	29	76	14	143
1992	10001 Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R A gene expression profile of Alzheimer's disease DNA AND CELL BIOLOGY. 2001 NOV; 20 (11): 683-695	81	136	9	143
1993	10906 Wang CX, Shuaib A Involvement of inflammatory cytokines in central nervous system injury PROGRESS IN NEUROBIOLOGY. 2002 JUN; 67 (2): 161-172	14	119	3	143
1994	11217 Zhu XW, Lee HG, Raina AK, Perry G, Smith MA The role of mitogen-activated protein kinase pathways in Alzheimer's disease NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 270-281	42	120	40	143
1995	11811 Lalonde R, Strazielle C Neurobehavioral characteristics of mice with modified intermediate filament genes REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 369-385	2	8	60	143
1996	12217 Pinkham AE, Penn DL, Perkins DO, Lieberman J Implications for the neural basis of social cognition for the study of schizophrenia AMERICAN JOURNAL OF PSYCHIATRY. 2003 MAY; 160 (5): 815-824	0	141	3	143
1997	13127 Enriquez P, Bullock R Molecular and cellular mechanisms in the pathophysiology of severe head injury CURRENT PHARMACEUTICAL DESIGN. 2004; 10 (18): 2131-2143	2	24	8	143
1998	13251 Calza L, Fernandez M, Giuliani A, Pirondi S, D'Intino G, et al. Stem cells and nervous tissue repair: from in vitro to in vivo NGF AND RELATED MOLECULES IN HEALTH AND DISEASE. 2004; 146: 75-91	0	9	7	143
1999	13936 LeVine H The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide JOURNAL OF ALZHEIMERS DISEASE. 2004 JUN; 6 (3): 303-314	1	6	28	143
2000	14383 von Bohlen und Halbach O Synucleins and their relationship to Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 163-174	11	15	97	143

Date / Author / Journal

LCS

GCS

LCR

1901

2181 KISILEVSKY R, LYON AW, YOUNG ID

A CRITICAL ANALYSIS OF POSTULATED PATHOGENETIC MECHANISMS IN AMYLOIDOGENESIS

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. 1992; 29 (1): 59-82

146

1902

4768 delaTorre JC

Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease

CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE. 1997; 826: 75-91

146

1903

5799 Rowland LP

Molecular basis of genetic heterogeneity: Role of the clinical neurologist

JOURNAL OF CHILD NEUROLOGY. 1998 MAR; 13 (3): 122-132

146

1904

5890 Rao BR

Isolation and characterization of an estrogen binding protein which may integrate the plethora of estrogenic actions in nonreproductive organs

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 1998 APR; 65 (1-6): 3-41

146

1905

6529 Litvan I

Progressive supranuclear palsy revisited (vol 98, pg 73, 1998)

ACTA NEUROLOGICA SCANDINAVICA. 1998 DEC; 98 (6): 468-A84

146

1906

7866 Kvetnoy IM, Hernandez-Yago J, Hernandez JM, Kvetnaia TV, Reiter RJ, et al.

Diffuse neuroendocrine system and mitochondrial diseases: molecular and cellular bases of pathogenesis, new approaches to diagnosis and therapy.

NEUROENDOCRINOLOGY LETTERS. 2000; 21 (2): 83-99

146

1907

8022 Philips AV, Cooper TA

RNA processing and human disease

CELLULAR AND MOLECULAR LIFE SCIENCES. 2000 FEB; 57 (2): 235-249

146

1908

8597 Shoichet MS, Winn SR

Cell delivery to the central nervous system

ADVANCED DRUG DELIVERY REVIEWS. 2000 AUG 20; 42 (1-2): 81-102

146

1909

8645 Alvarado MC, Bachevalier J

Revisiting the maturation of medial temporal lobe memory functions in primates

LEARNING & MEMORY. 2000 SEP-OCT; 7 (5): 244-256

146

1910

9528 Fuster JM

The prefrontal cortex - An update: time is of the essence

NEURON. 2001 MAY; 30 (2): 319-333

418

146

Date / Author / Journal

LCS

GCS

LCR

1911

9697 Chambers RA, Krystal JH, Self DW

A neurobiological basis for substance abuse comorbidity in schizophrenia

BIOLOGICAL PSYCHIATRY. 2001 JUL 15; 50 (2): 71-83

143

146

1912

10452 Springer JE

Apoptotic cell death following traumatic injury to the central nervous system

JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2002 JAN 31; 35 (1): 94-105

146

1913

10801 Grundman M, Delaney P

Antioxidant strategies for Alzheimer's disease

PROCEEDINGS OF THE NUTRITION SOCIETY. 2002 MAY; 61 (2): 191-202

146

1914

11059 Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, et al.

Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice

JOURNAL OF COMPARATIVE NEUROLOGY. 2002 JUL 29; 449 (3): 241-269

146

1915

13028 Shah AC, Benos D, Gillespie GY, Markert JM

Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas

JOURNAL OF NEURO-ONCOLOGY. 2003 DEC; 65 (3): 203-226

146

1916

13636 Barcia-Gonzalez C, Herrero-Ezquerro MT

Inflammation and Parkinson's disease

REVISTA DE NEUROLOGIA. 2004 MAR 16; 38 (6): 545-553

146

1917

13791 Kreuter M, Langer C, Kerkhoff C, Reddanna P, Kania AL, et al.

Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2004 MAY-JUN; 52 (3): 141-155

146

1918

14097 Fujimoto ST, Longhi L, Saatman KE, McIntosh TK

Motor and cognitive function evaluation following experimental traumatic brain injury

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2004 JUL; 28 (4): 365-378

146

1919

14611 Rao RV, Bredesen DE

Misfolded proteins, endoplasmic reticulum stress and neurodegeneration

CURRENT OPINION IN CELL BIOLOGY. 2004 DEC; 16 (6): 653-662

146

1920

15565 Hoerndli F, David DC, Gotz J

Functional genomics meets neurodegenerative disorders Part II: Application and data integration

PROGRESS IN NEUROBIOLOGY. 2005 JUN; 76 (3): 169-188

146

Date / Author / Journal

LCS

GCS

LCR

1921

15846 Gille G, Reichmann H

Update on etiopathogenesis of idiopathic Parkinson's syndrome

AKTUELLE NEUROLOGIE. 2005 SEP; 32: S75-S87

146

1922

16433 Gilgun-Sherki Y, Melamed E, Offen D

Anti-inflammatory drugs in the treatment of neurodegenerative diseases: Current state

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (27): 3509-3519

146

1923

18256 Gnanapavan S, Giovannoni G

Incorporation of other biomarkers

NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207

146

1924

18294 Biasca N, Maxwell WL

Minor traumatic brain injury in sports: a review in order to prevent neurological sequelae

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 263-291

146

1925

19010 Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G

ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation

PROCEEDINGS OF THE NUTRITION SOCIETY. 2007 MAY; 66 (2): 183-197

146

1926

19109 Walsh DM, Selkoe DJ

A beta Oligomers - a decade of discovery

JOURNAL OF NEUROCHEMISTRY. 2007 JUN; 101 (5): 1172-1184

334

146

1927

19288 LaFerla FM, Green KN, Oddo S

Intracellular amyloid-beta in Alzheimer's disease

NATURE REVIEWS NEUROSCIENCE. 2007 JUL; 8 (7): 499-509

231

146

1928

20775 Nathalie P, Jean-Noel O

Processing of amyloid precursor protein and amyloid peptide neurotoxicity

CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 92-99

146

1929

22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G

Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406

146

1930

22742 Weiss MJ, dos Santos CO

Chaperoning erythropoiesis

BLOOD. 2009 MAR 5; 113 (10): 2136-2144

146

Date / Author / Journal

LCS

GCS

LCR

1931

24929 Selvaraj S, Sun YY, Singh BB

TRPC Channels and their Implications for Neurological Diseases

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 MAR; 9 (1): 94-104

146

1932

25070 Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH

Mechanisms Underlying Inflammation in Neurodegeneration

CELL. 2010 MAR 19; 140 (6): 918-934

146

1933

25169 Schwartz M, Shechter R

Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease

MOLECULAR PSYCHIATRY. 2010 APR; 15 (4): 342-354

146

1934

25246 Yeager MP, Coleman RA

In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease

JOURNAL OF NEUROSCIENCE METHODS. 2010 APR 30; 188 (1): 151-164

146

1935

26777 Tyther R, McDonagh B, Sheehan D

PROTEOMICS IN INVESTIGATION OF PROTEIN NITRATION IN KIDNEY DISEASE: TECHNICAL CHALLENGES AND PERSPECTIVES FROM THE SPONTANEOUSLY HYPERTENSIVE RAT

MASS SPECTROMETRY REVIEWS. 2011 JAN-FEB; 30 (1): 121-141

146

1936

844 LEICHNETZ GR

AFFERENT AND EFFERENT CONNECTIONS OF THE DORSOLATERAL PRECENTRAL GYRUS (AREA-4, HAND ARM REGION) IN THE MACAQUE MONKEY, WITH COMPARISONS TO AREA-8

JOURNAL OF COMPARATIVE NEUROLOGY. 1986 DEC 22; 254 (4): 460-492

164

145

1937

3726 HOF PR, GIANNAKOPOULOS P, VICKERS JC, BOURAS C, MORRISON JH

THE MORPHOLOGIC AND NEUROCHEMICAL BASIS OF DEMENTIA - AGING, HIERARCHICAL PATTERNS OF LESION DISTRIBUTION AND VULNERABLE NEURONAL PHENOTYPE

REVIEWS IN THE NEUROSCIENCES. 1995 APR-JUN; 6 (2): 97-124

145

1938

5277 Verbeek MM, Ruiter DJ, deWaal RMW

The role of amyloid in the pathogenesis of Alzheimer's disease

BIOLOGICAL CHEMISTRY. 1997 SEP; 378 (9): 937-950

145

1939

9322 Grant P, Sharma P, Pant HC

Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism

EUROPEAN JOURNAL OF BIOCHEMISTRY. 2001 MAR; 268 (6): 1534-1546

145

1940

10009 Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, et al.

A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2001 NOV; 21 (11): 1241-1258

145

Date / Author / Journal

1941

Models of repair mechanisms for future treatment modalities of Parkinson's disease

BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 839-846

145

1942

11007 Gwinn-Hardy K

Genetics of parkinsonism

MOVEMENT DISORDERS. 2002 JUL; 17 (4): 645-656

145

1943

12017 Huang ZA, de la Fuente-Fernandez R, Stoessl AJ

Etiology of Parkinson's disease

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2003 MAR; 30: S10-S18

145

1944

13124 Willcox JK, Ash SL, Catignani GL

Antioxidants and prevention of chronic disease

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION. 2004; 44 (4): 275-295

138

145

1945

13671 Rao RV, Ellerby HM, Bredesen DE

Coupling endoplasmic reticulum stress to the cell death program

CELL DEATH AND DIFFERENTIATION. 2004 APR; 11 (4): 372-380

296

145

1946

13682 Sidhu A, Wersinger C, Vernier P

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

FASEB JOURNAL. 2004 APR; 18 (6): 637-647

145

1947

13833 Verdier Y, Zarandi M, Penke B

Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer's disease

JOURNAL OF PEPTIDE SCIENCE. 2004 MAY; 10 (5): 229-248

145

1948

14106 Nakaya K

Basic studies for the development of anticancer, antidementia, and taste modifier drugs

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. 2004 JUL; 124 (7): 371-396

145

1949

15128 Pereira AA, Weiner DE, Scott T, Sarnak MJ

Cognitive function in dialysis patients

AMERICAN JOURNAL OF KIDNEY DISEASES. 2005 MAR; 45 (3): 448-462

145

1950

15270 Marchetti B, Serra PA, Tirolo C, L'Episcopo F, Caniglia S, et al.

Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions

BRAIN RESEARCH REVIEWS. 2005 APR; 48 (2): 302-321

145

Date / Author / Journal

LCS

GCS

LCR

1951

15272 Schmidt OI, Heyde CE, Ertel W, Stahel PF

Closed head injury - an inflammatory disease?

BRAIN RESEARCH REVIEWS. 2005 APR; 48 (2): 388-399

145

1952

15521 Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX

Metals and amyloid-beta in Alzheimer's disease

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 2005 JUN; 86 (3): 147-159

145

1953

16019 Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B

Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2005 OCT; 47 (10): 1059-1087

145

1954

16966 Chaudhuri TK, Paul S

Protein-misfolding diseases and chaperone-based therapeutic approaches

FEBS JOURNAL. 2006 APR; 273 (7): 1331-1349

145

1955

17995 Rubin CD

The primary care of Alzheimer disease

AMERICAN JOURNAL OF THE MEDICAL SCIENCES. 2006 DEC; 332 (6): 314-333

145

1956

19095 Quinones-Hinojosa A, Chaichana K

The human subventricular zone: A source of new cells and a potential source of brain tumors

EXPERIMENTAL NEUROLOGY. 2007 JUN; 205 (2): 313-324

145

1957

20463 Hess DC, Borlongan CV

Stem cells and neurological diseases

CELL PROLIFERATION. 2008 FEB; 41: 94-114

145

1958

20564 Alavian KN, Scholz C, Simon HH

Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death

MOVEMENT DISORDERS. 2008 FEB 15; 23 (3): 319-328

145

1959

20609 Otzen D, Nielsen PH

We find them here, we find them there: Functional bacterial amyloid

CELLULAR AND MOLECULAR LIFE SCIENCES. 2008 MAR; 65 (6): 910-927

145

1960

21575 Martinez A

Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs

MEDICINAL RESEARCH REVIEWS. 2008 SEP; 28 (5): 773-796

145

Date / Author / Journal

LCS

GCS

LCR

1961

22102 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, et al.

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS. 2009; 10 (3): 131-146

145

1962

22676 Beyer K, Domingo-Sabat M, Ariza A

Molecular Pathology of Lewy Body Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745

145

1963

22830 Fatemi SH

POTENTIAL MICROBIAL ORIGINS OF SCHIZOPHRENIA AND THEIR TREATMENTS

DRUGS OF TODAY. 2009 APR; 45 (4): 305-318

145

1964

23361 Friedman GK, Pressey JG, Reddy AT, Markert JM, Gillespie GY

Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies

MOLECULAR THERAPY. 2009 JUL; 17 (7): 1125-1135

145

1965

23632 Fernandes A, Brites D

Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents

CURRENT PHARMACEUTICAL DESIGN. 2009 SEP; 15 (25): 2915-2926

145

1966

24464 Fahn S

Parkinson's Disease: 10 Years of Progress, 1997-2007

MOVEMENT DISORDERS. 2010; 25 (3): S2-S14

145

1967

3527 Jellinger KA

Neurodegenerative disorders with extrapyramidal features - A neuropathological overview

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1995; (46): 33-57

144

1968

4556 Beauregard M, Bachevalier J

Neonatal insult to the hippocampal region and schizophrenia: A review and a putative animal model

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 1996 SEP; 41 (7): 446-456

144

1969

4942 PallaresTrujillo J, Agell N, GarciaMartinez C, LopezSoriano FJ, Argiles JM

The ubiquitin system: A role in disease?

MEDICINAL RESEARCH REVIEWS. 1997 MAR; 17 (2): 139-161

144

1970

5079 daSilva HAR, Patel AJ

Presenilins and early-onset familial Alzheimer's disease

NEUROREPORT. 1997 MAY 27; 8 (8): R1-R12

144

Date / Author / Journal

LCS

GCS

LCR

1971

5318 Price DL, Wong PC, Borchelt DR, Pardo CA, Thinakaran G, et al.

Amyotrophic lateral sclerosis and Alzheimer's disease. Lessons from model systems

REVUE NEUROLOGIQUE. 1997 SEP; 153 (8-9): 484-495

144

1972

7514 Herschkowitz N, Kagan J, Zilles K

Neurobiological bases of behavioral development in the second year

NEUROPEDIATRICS. 1999 OCT; 30 (5): 221-230

144

1973

9075 Lowe J, Mayer J, Landon M, Layfield R

Ubiquitin and the molecular pathology of neurodegenerative diseases

NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 169-186

144

1974

11460 Morelli L, Llovera R, Ibendahl S, Castano EM

The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses

NEUROCHEMICAL RESEARCH. 2002 NOV; 27 (11): 1387-1399

144

1975

14381 Schulz JB, Falkenburger BH

Neuronal pathology in Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 135-147

144

1976

14907 Povlishock JT, Katz DI

Update of neuropathology and neurological recovery after traumatic brain injury

JOURNAL OF HEAD TRAUMA REHABILITATION. 2005 JAN-FEB; 20 (1): 76-94

102

144

1977

15407 Spires TL, Hannan AJ

Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease - FEBS anniversary prize lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw

FEBS JOURNAL. 2005 MAY; 272 (10): 2347-2361

144

1978

19428 Tilleux S, Hermans E

Neuroinflammation and regulation of glial glutamate uptake in neurological disorders

JOURNAL OF NEUROSCIENCE RESEARCH. 2007 AUG 1; 85 (10): 2059-2070

144

1979

19784 Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA

gamma-synuclein and the progression of cancer

FASEB JOURNAL. 2007 NOV; 21 (13): 3419-3430

144

1980

19881 Klein C, Schlossmacher MG

Parkinson disease, 10 years after its genetic revolution - Multiple clues to a complex disorder

NEUROLOGY. 2007 NOV 27; 69 (22): 2093-2104

144

Date / Author / Journal

LCS

GCS

LCR

1981

20063 Sano M, Grossman H, Van Dyk K

Preventing Alzheimer's Disease Separating Fact From Fiction

CNS DRUGS. 2008; 22 (11): 887-902

144

1982

21163 Schiesling C, Kieper N, Seidel K, Kruger R

Review: Familial Parkinson's disease - genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 JUN; 34 (3): 255-271

144

1983

22878 Head E

Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging

NEUROCHEMICAL RESEARCH. 2009 APR; 34 (4): 670-678

144

1984

23653 Green KN

Calcium in the initiation, progression and as an effector of Alzheimer's disease pathology

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 SEP; 13 (9A): 2787-2799

144

1985

24032 Mason C, Dunnill P

Assessing the value of autologous and allogeneic cells for regenerative medicine

REGENERATIVE MEDICINE. 2009 NOV; 4 (6): 835-853

144

1986

24919 Crews L, Rockenstein E, Masliah E

APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis

BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 111-126

144

1987

25608 Sreedharan J

Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics?

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 259-267

144

1988

834 HUERTA MF, KRUBITZER LA, KAAS JH

FRONTAL EYE FIELD AS DEFINED BY INTRACORTICAL MICROSTIMULATION IN SQUIRREL-MONKEYS, OWL MONKEYS, AND MACAQUE MONKEYS .1. SUBCORTICAL CONNECTIONS

JOURNAL OF COMPARATIVE NEUROLOGY. 1986 NOV 22; 253 (4): 415-439

238

143

1989

6180 Litvan I

Progressive supranuclear palsy revisited

ACTA NEUROLOGICA SCANDINAVICA. 1998 AUG; 98 (2): 73-84

143

1990

7239 Arnold SE

Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology

DEVELOPMENT AND PSYCHOPATHOLOGY. 1999 SUM; 11 (3): 439-456

143

Date / Author / Journal

LCS

GCS

LCR

1991

9762 Sathasivam S, Ince PG, Shaw PJ

Apoptosis in amyotrophic lateral sclerosis: a review of the evidence

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 AUG; 27 (4): 257-274

143

1992

10001 Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R

A gene expression profile of Alzheimer's disease

DNA AND CELL BIOLOGY. 2001 NOV; 20 (11): 683-695

136

143

1993

10906 Wang CX, Shuaib A

Involvement of inflammatory cytokines in central nervous system injury

PROGRESS IN NEUROBIOLOGY. 2002 JUN; 67 (2): 161-172

119

143

1994

11217 Zhu XW, Lee HG, Raina AK, Perry G, Smith MA

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 270-281

120

143

1995

11811 Lalonde R, Strazielle C

Neurobehavioral characteristics of mice with modified intermediate filament genes

REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 369-385

143

1996

12217 Pinkham AE, Penn DL, Perkins DO, Lieberman J

Implications for the neural basis of social cognition for the study of schizophrenia

AMERICAN JOURNAL OF PSYCHIATRY. 2003 MAY; 160 (5): 815-824

141

143

1997

13127 Enriquez P, Bullock R

Molecular and cellular mechanisms in the pathophysiology of severe head injury

CURRENT PHARMACEUTICAL DESIGN. 2004; 10 (18): 2131-2143

143

1998

13251 Calza L, Fernandez M, Giuliani A, Pirondi S, D'Intino G, et al.

Stem cells and nervous tissue repair: from in vitro to in vivo

143

1999

13936 LeVine H

The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide

JOURNAL OF ALZHEIMERS DISEASE. 2004 JUN; 6 (3): 303-314

143

2000

14383 von Bohlen und Halbach O

Synucleins and their relationship to Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 163-174

143

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records